porphyria cutanea tarda
MeSH: D017119ORPHA: 101330
Overview
acute porphyria characterized by painful, blistering skin lesions that develop on sun-exposed skin
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with porphyria cutanea tarda, sourced from HPO and Orphanet clinical annotations.
Abnormal circulating enzyme concentration or activityAbnormal erythrocyte enzyme concentration or activityIncreased circulating ferritin concentrationElevated hepatic iron concentrationDecreased circulating hepcidin concentrationAddictive alcohol useChronic hepatitisSystemic lupus erythematosusStage 5 chronic kidney diseaseDiabetes mellitusHepatic steatosisHematological neoplasmCutaneous photosensitivityAbnormal blistering of the skinFragile skinScaling skinPoor wound healingPainRecurrent bacterial skin infectionsCutaneous abscessHypertrichosisHypopigmentation of the skinHyperpigmentation of the skinHirsutismScarringCorneal scarringEctropionElevated circulating hepatic transaminase concentrationPeriportal fibrosisHepatic lobular inflammationPortal inflammationHepatocellular carcinomaPorphyrinuriaAbnormal circulating porphyrin concentrationIncreased fecal porphyrinIncreased urinary porphobilinogenIncreased circulating iron concentrationViral hepatitis
Classification & Codes
MeSH Code
D017119Orphanet Code
ORPHA:101330porphyria cutanea tarda
| MeSH | D017119 |
| Orphanet | ORPHA:101330 |
| Treatments | 0 drug(s) |
| Symptoms on record | 38 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO